We are live on ! Find out more
AWM

Aevitas Wealth Management Portfolio holdings

AUM $169M
1-Year Est. Return 9.55%
This Fund
S&P 500
This Quarter Est. Return
+8.04%
1 Year Est. Return
-9.55%
3 Year Est. Return
+36.41%
5 Year Est. Return
+72.53%
10 Year Est. Return
AUM
$157M
AUM Growth
+$13.2M
Cap. Flow
+$2.83M
Cap. Flow %
1.81%
Top 10 Hldgs %
37.62%
Holding
126
New
8
Increased
81
Reduced
22
Closed
3

Sector Composition

Rank Sector Weight
1 Technology 22.33%
2 Healthcare 13.97%
3 Consumer Staples 10.01%
4 Consumer Discretionary 7.97%
5 Communication Services 6.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PEG icon
51
Public Service Enterprise Group
PEG
$39.5B
$872K 0.56%
14,600
-38
-0.3% -$2.35K
UL icon
52
Unilever
UL
$132B
$850K 0.54%
12,922
+39
+0.3% +$2.59K
VNQ icon
53
Vanguard Real Estate ETF
VNQ
$39.8B
$843K 0.54%
8,280
+2,643
+47% +$262K
CL icon
54
Colgate-Palmolive
CL
$73.6B
$827K 0.53%
10,168
+205
+2% +$16.8K
BRK.B icon
55
Berkshire Hathaway Class B
BRK.B
$1.07T
$813K 0.52%
2,927
+128
+5% +$35.8K
AEP icon
56
American Electric Power
AEP
$72.7B
$802K 0.51%
9,478
-343
-3% -$29.5K
RTX icon
57
RTX Corp
RTX
$294B
$769K 0.49%
9,011
+498
+6% +$41.9K
EFX icon
58
Equifax
EFX
$20.8B
$768K 0.49%
3,207
+3
+0.1% +$670
PAYX icon
59
Paychex
PAYX
$41.1B
$731K 0.47%
6,809
+9
+0.1% +$905
VDC icon
60
Vanguard Consumer Staples ETF
VDC
$7.98B
$720K 0.46%
3,942
+58
+1% +$10.6K
MKC icon
61
McCormick & Company Non-Voting
MKC
$13.6B
$716K 0.46%
8,105
+13
+0.2% +$1.16K
CRSP icon
62
CRISPR Therapeutics
CRSP
$4.6B
$694K 0.44%
4,287
+300
+8% +$36.5K
MDT icon
63
Medtronic
MDT
$108B
$662K 0.42%
5,335
-85
-2% -$10.7K
VYM icon
64
Vanguard High Dividend Yield ETF
VYM
$81.3B
$659K 0.42%
6,294
+518
+9% +$54.4K
IJJ icon
65
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8.87B
$623K 0.4%
+5,918
New +$632K
CME icon
66
CME Group
CME
$92.3B
$612K 0.39%
2,876
+1
+0% +$211
NTLA icon
67
Intellia Therapeutics
NTLA
$1.49B
$607K 0.39%
3,750
ABT icon
68
Abbott
ABT
$182B
$601K 0.38%
5,184
+363
+8% +$42.3K
BSCL
69
DELISTED
Invesco BulletShares 2021 Corporate Bond ETF
BSCL
$600K 0.38%
28,415
-3,878
-12% -$81.9K
ORCL icon
70
Oracle
ORCL
$345B
$593K 0.38%
7,619
-184
-2% -$14.4K
CRM icon
71
Salesforce
CRM
$142B
$579K 0.37%
2,369
+230
+11% +$53K
GS icon
72
Goldman Sachs
GS
$309B
$549K 0.35%
1,446
+4
+0.3% +$1.43K
EVRG icon
73
Evergy
EVRG
$19.8B
$547K 0.35%
9,044
+18
+0.2% +$1.13K
V icon
74
Visa
V
$689B
$544K 0.35%
2,329
+255
+12% +$58.3K
VAW icon
75
Vanguard Materials ETF
VAW
$3.01B
$542K 0.35%
2,997
+1,259
+72% +$232K

Similar funds

Aevitas Wealth Management's Q2 2021 Portfolio in Review

As of Q2 2021, Aevitas Wealth Management held 126 positions worth $157M, up 9.2% from $143M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Aevitas Wealth Management's Q2 2021 filing shows 8 new, 81 increased, 22 reduced and 3 closed positions. Its largest new stake was Enbridge: 30,087 shares worth $1.21M. The largest sale was SPDR Gold Trust, an estimated $2.86M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Aevitas Wealth Management's largest Q2 2021 buy was Enbridge: 30,087 shares worth $1.21M.
  • Aevitas Wealth Management added most to Microsoft in Q2 2021, an estimated $549K increase.
  • Aevitas Wealth Management's biggest Q2 2021 reduction was SPDR Gold Trust, cutting an estimated $2.86M.
  • Aevitas Wealth Management fully exited State Street SPDR Bloomberg Convertible Securities ETF in Q2 2021, selling an estimated $467K.
  • Aevitas Wealth Management's ten largest holdings make up 38% of its $157M portfolio in Q2 2021.
  • Aevitas Wealth Management opened 8 new positions and closed 3 in Q2 2021.
  • Aevitas Wealth Management's portfolio value rose 9.2% quarter-over-quarter to $157M.

Based on Aevitas Wealth Management's 13F filing for Q2 2021, filed 22 Jul 2021.